Christopher Cashman is the founder of Marinus Pharmaceuticals. Marinus Pharmaceuticals has raised $21M in total funding. Latest round: Series C.
Christopher Cashman served as the chief executive officer of Marinus Pharmaceuticals for eight years. During his leadership, Marinus advanced the development of ganaxolone into pivotal studies for rare pediatric genetic epilepsies, and phase 2 clinical studies for refractory status epilepticus and postpartum depression.
Full founder directory · Investor directory · Company funding database · Fundraising library